TipRanks
Advertisement
Advertisement
NAGE Shines Spotlight on New NAD+ Skin‑Aging Trial as Cosmetic Demand Heats Up
PremiumCompany AnnouncementsNAGE Shines Spotlight on New NAD+ Skin‑Aging Trial as Cosmetic Demand Heats Up
1M ago
Meet Niagen Bioscience: Fly exclusive interview with CFO Ozan Pamir
Premium
The Fly
Meet Niagen Bioscience: Fly exclusive interview with CFO Ozan Pamir
2M ago
Niagen CFO says core business ‘cash flow positive with no dilution risk’
Premium
The Fly
Niagen CFO says core business ‘cash flow positive with no dilution risk’
2M ago
Niagen Bioscience Under Pressure: FDA-Approved NMN Intensifies Competition, Pricing Strain, and Growth Uncertainty
PremiumCompany AnnouncementsNiagen Bioscience Under Pressure: FDA-Approved NMN Intensifies Competition, Pricing Strain, and Growth Uncertainty
2M ago
Niagen Bioscience price target lowered to $10 from $12 at Roth Capital
Premium
The Fly
Niagen Bioscience price target lowered to $10 from $12 at Roth Capital
2M ago
Analyst Reiterates Buy on Niagen Bioscience, Maintains $11 Price Target Despite 2Q26 Shortfall
Premium
Ratings
Analyst Reiterates Buy on Niagen Bioscience, Maintains $11 Price Target Despite 2Q26 Shortfall
2M ago
NAGE Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsNAGE Upcoming Earnings Report: What to Expect?
2M ago
Niagen Bioscience announces publication on muscle epigenetic age
Premium
The Fly
Niagen Bioscience announces publication on muscle epigenetic age
2M ago
Niagen Bioscience price target lowered to $11 from $12 at Ladenburg
Premium
The Fly
Niagen Bioscience price target lowered to $11 from $12 at Ladenburg
2M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―